Role of oxidative stress in the chemical structure-related genotoxicity of nitrofurantoin in <i>Nrf2</i>-deficient <i>gpt</i> delta mice-Reference-Cited by-同舟云学术

Role of oxidative stress in the chemical structure-related genotoxicity of nitrofurantoin in Nrf2-deficient gpt delta mice

Published:2018 Issue:3 Volume:31 Page:169-178
ISSN:0914-9198
Container-title:Journal of Toxicologic Pathology
language:en
Short-container-title:J Toxicol Pathol

Author:

Tsuchiya Takuma¹²,Kijima Aki¹,Ishii Yuji¹,Takasu Shinji¹,Yokoo Yuh¹,Nishikawa Akiyoshi¹,Yanai Tokuma²,Umemura Takashi¹³

Affiliation:

1. Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan

2. Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan

3. Department of Animal Nursing, Yamazaki Gakuen University, 4-7-2 Minamiosawa, Hachioji-shi, Tokyo 192-0364, Japan

Publisher

Japanese Society of Toxicologic Pathology

Subject

Toxicology,Pathology and Forensic Medicine

Link

https://www.jstage.jst.go.jp/article/tox/31/3/31_2018-0014/_pdf

Reference32 articles.

1. 1. IARC Working Group on the Evaluation of the Carcinogenic Risk to Humans Furaltadone. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 7, International Agency for Research on Cancer, Lyon. 161–169. 1974.

2. 2. IARC Working Group on the Evaluation of the Carcinogenic Risk to Humans Furazolidone. In: IARC Monographs on the Evaluation of the Carcinogenic Risk to Humans, vol. 31, International Agency for Research on Cancer, Lyon. 1983.

3. 3. IARC Working Group on the Evaluation of the Carcinogenic Risk to Humans Nitrofural (nitrofurazone). In: IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans, vol. 50, International Agency for Research on Cancer, Lyon. 195–209. 1990.

4. 4. IARC Working Group on the Evaluation of the Carcinogenic Risk to Humans. Nitrofurantoin. In: IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol. 50, International Agency for Research on Cancer, Lyon. 211–231. 1990.

5. 5. Zorzi RR, Jorge SD, Palace-Berl F, Pasqualoto KF, Bortolozzo LS, de Castro Siqueira AM, and Tavares LC. Exploring 5-nitrofuran derivatives against nosocomial pathogens: synthesis, antimicrobial activity and chemometric analysis. Bioorg Med Chem. 22: 2844–2854. 2014.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion of Nitrofurantoin into the Realm of Cancer Chemotherapy via Biology-Oriented Synthesis and Drug Repurposing;Journal of Medicinal Chemistry;2023-03-15

2. Nitrofurazone repurposing towards design and synthesis of novel apoptotic-dependent anticancer and antimicrobial agents: Biological evaluation, kinetic studies and molecular modeling;Bioorganic Chemistry;2021-08

3. Risk of Cancer after Lower Urinary Tract Infection: A Population-Based Cohort Study;International Journal of Environmental Research and Public Health;2019-01-30

4. A systematic analysis of Nrf2 pathway activation dynamics during repeated xenobiotic exposure;Archives of Toxicology;2018-11-20

5. Mechanisms of oxidative stress-induced in vivo mutagenicity by potassium bromate and nitrofurantoin;Journal of Toxicologic Pathology;2018